Literature DB >> 24436503

Resampling Procedures for Making Inference under Nested Case-control Studies.

Tianxi Cai1, Yingye Zheng2.   

Abstract

The nested case-control (NCC) design have been widely adopted as a cost-effective solution in many large cohort studies for risk assessment with expensive markers, such as the emerging biologic and genetic markers. To analyze data from NCC studies, conditional logistic regression (Goldstein and Langholz, 1992; Borgan et al., 1995) and maximum likelihood (Scheike and Juul, 2004; Zeng et al., 2006) based methods have been proposed. However, most of these methods either cannot be easily extended beyond the Cox model (Cox, 1972) or require additional modeling assumptions. More generally applicable approaches based on inverse probability weighting (IPW) have been proposed as useful alternatives (Samuelsen, 1997; Chen, 2001; Samuelsen et al., 2007). However, due to the complex correlation structure induced by repeated finite risk set sampling, interval estimation for such IPW estimators remain challenging especially when the estimation involves non-smooth objective functions or when making simultaneous inferences about functions. Standard resampling procedures such as the bootstrap cannot accommodate the correlation and thus are not directly applicable. In this paper, we propose a resampling procedure that can provide valid estimates for the distribution of a broad class of IPW estimators. Simulation results suggest that the proposed procedures perform well in settings when analytical variance estimator is infeasible to derive or gives less optimal performance. The new procedures are illustrated with data from the Framingham Offspring Study to characterize individual level cardiovascular risks over time based on the Framingham risk score, C-reactive protein (CRP) and a genetic risk score.

Entities:  

Keywords:  Biomarker study; Interval Estimation; Inverse Probability Weighting; Nested case-control study; Resampling methods, Risk Prediction; Simultaneous Confidence Band; Survival Model

Year:  2013        PMID: 24436503      PMCID: PMC3891801          DOI: 10.1080/01621459.2013.856715

Source DB:  PubMed          Journal:  J Am Stat Assoc        ISSN: 0162-1459            Impact factor:   5.033


  29 in total

1.  Weighted analyses for cohort sampling designs.

Authors:  Robert J Gray
Journal:  Lifetime Data Anal       Date:  2008-08-19       Impact factor: 1.588

2.  Evaluating prognostic accuracy of biomarkers in nested case-control studies.

Authors:  Tianxi Cai; Yingye Zheng
Journal:  Biostatistics       Date:  2011-08-19       Impact factor: 5.899

3.  Nonparametric estimation of relative mortality from nested case-control studies.

Authors:  O Borgan; B Langholz
Journal:  Biometrics       Date:  1993-06       Impact factor: 2.571

4.  Association between a literature-based genetic risk score and cardiovascular events in women.

Authors:  Nina P Paynter; Daniel I Chasman; Guillaume Paré; Julie E Buring; Nancy R Cook; Joseph P Miletich; Paul M Ridker
Journal:  JAMA       Date:  2010-02-17       Impact factor: 56.272

5.  General cardiovascular risk profile for use in primary care: the Framingham Heart Study.

Authors:  Ralph B D'Agostino; Ramachandran S Vasan; Michael J Pencina; Philip A Wolf; Mark Cobain; Joseph M Massaro; William B Kannel
Journal:  Circulation       Date:  2008-01-22       Impact factor: 29.690

6.  Relevance of genetics and genomics for prevention and treatment of cardiovascular disease: a scientific statement from the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group.

Authors:  Donna K Arnett; Alison E Baird; Ruth A Barkley; Craig T Basson; Eric Boerwinkle; Santhi K Ganesh; David M Herrington; Yuling Hong; Cashell Jaquish; Deborah A McDermott; Christopher J O'Donnell
Journal:  Circulation       Date:  2007-05-21       Impact factor: 29.690

7.  A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer.

Authors:  Kana Wu; Diane Feskanich; Charles S Fuchs; Walter C Willett; Bruce W Hollis; Edward L Giovannucci
Journal:  J Natl Cancer Inst       Date:  2007-07-10       Impact factor: 13.506

8.  Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study.

Authors:  Aruna D Pradhan; JoAnn E Manson; Jacques E Rossouw; David S Siscovick; Charles P Mouton; Nader Rifai; Robert B Wallace; Rebecca D Jackson; Mary B Pettinger; Paul M Ridker
Journal:  JAMA       Date:  2002-08-28       Impact factor: 56.272

9.  Calcium plus vitamin D supplementation and the risk of breast cancer.

Authors:  Rowan T Chlebowski; Karen C Johnson; Charles Kooperberg; Mary Pettinger; Jean Wactawski-Wende; Tom Rohan; Jacques Rossouw; Dorothy Lane; Mary Jo O'Sullivan; Shagufta Yasmeen; Robert A Hiatt; James M Shikany; Mara Vitolins; Janu Khandekar; F Allan Hubbell
Journal:  J Natl Cancer Inst       Date:  2008-11-11       Impact factor: 13.506

10.  Inflammatory markers and risk of developing type 2 diabetes in women.

Authors:  Frank B Hu; James B Meigs; Tricia Y Li; Nader Rifai; JoAnn E Manson
Journal:  Diabetes       Date:  2004-03       Impact factor: 9.461

View more
  9 in total

1.  Estimation and inference for semi-competing risks based on data from a nested case-control study.

Authors:  Ina Jazić; Stephanie Lee; Sebastien Haneuse
Journal:  Stat Methods Med Res       Date:  2020-06-17       Impact factor: 3.021

2.  Generalized mean residual life models for case-cohort and nested case-control studies.

Authors:  Peng Jin; Anne Zeleniuch-Jacquotte; Mengling Liu
Journal:  Lifetime Data Anal       Date:  2020-06-11       Impact factor: 1.588

3.  Evaluating longitudinal markers under two-phase study designs.

Authors:  Marlena Maziarz; Tianxi Cai; Li Qi; Anna S Lok; Yingye Zheng
Journal:  Biostatistics       Date:  2019-07-01       Impact factor: 5.899

4.  Design and analysis of nested case-control studies for recurrent events subject to a terminal event.

Authors:  Ina Jazić; Sebastien Haneuse; Benjamin French; Gaëtan MacGrogan; Virginie Rondeau
Journal:  Stat Med       Date:  2019-07-09       Impact factor: 2.373

5.  Model-free scoring system for risk prediction with application to hepatocellular carcinoma study.

Authors:  Weining Shen; Jing Ning; Ying Yuan; Anna S Lok; Ziding Feng
Journal:  Biometrics       Date:  2017-07-25       Impact factor: 2.571

6.  Assessing incremental value of biomarkers with multi-phase nested case-control studies.

Authors:  Qian M Zhou; Yingye Zheng; Lori B Chibnik; Elizabeth W Karlson; Tianxi Cai
Journal:  Biometrics       Date:  2015-07-20       Impact factor: 2.571

7.  Re-calibrating pure risk integrating individual data from two-phase studies with external summary statistics.

Authors:  Jiayin Zheng; Yingye Zheng; Li Hsu
Journal:  Biometrics       Date:  2021-08-13       Impact factor: 2.571

8.  Robust risk prediction with biomarkers under two-phase stratified cohort design.

Authors:  Rebecca Payne; Ming Yang; Yingye Zheng; Majken K Jensen; Tianxi Cai
Journal:  Biometrics       Date:  2016-04-01       Impact factor: 2.571

9.  Semiparametric isotonic regression analysis for risk assessment under nested case-control and case-cohort designs.

Authors:  Wen Li; Ruosha Li; Ziding Feng; Jing Ning
Journal:  Stat Methods Med Res       Date:  2019-12-22       Impact factor: 3.021

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.